Literature DB >> 24729709

Anterior capsulotomy improves persistent developmental stuttering with a psychiatric disorder: a case report and literature review.

Shizhen Zhang1, Peng Li1, Zhujun Zhang1, Wei Wang1.   

Abstract

Stuttering is characterized by disrupted fluency of verbal expression, and occurs mostly in children. Persistent developmental stuttering (PDS) may occur in adults. Reports of the surgical management of PDS are limited. Here we present the case of a 28-year-old man who had had PDS since the age of 7 years, was diagnosed with depression and anxiety disorder at the age of 24 years, and had physical concomitants. He underwent a bilateral anterior capsulotomy 4 years after the diagnosis. Over one year of follow-up, his physical concomitants resolved, and significant improvements in his psychiatric disorders and PDS were observed. To the best of our knowledge, this is the first report of simultaneous improvement in a patient's PDS and psychiatric disorder after a bilateral anterior capsulotomy.

Entities:  

Keywords:  anterior capsulotomy; persistent developmental stuttering; psychiatric disorders

Year:  2014        PMID: 24729709      PMCID: PMC3979796          DOI: 10.2147/NDT.S58984

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


Introduction

Stuttering is a disorder defined by frequent prolongations, repetitions, or blocks of spoken sounds and/or syllables, as well as anxiety and cognitive avoidance. Coexisting symptoms may include facial grimacing and tremors of the muscles involved in speech.1 Stuttering affects approximately 5% of children and 1% of the adult population.1 Most stuttering undergoes spontaneous recovery.1 Speech and language therapy is the most common treatment for stuttering.2 Persistent developmental stuttering (PDS) is a form of stuttering that occurs in early childhood and does not resolve spontaneously or respond to speech therapy.3 Many PDS patients have an increased risk of psychiatric and behavioral problems.4 Although successful surgical management of patients with refractory psychiatric disorders has been reported,5,6 the evidence for surgical treatment of PDS and associated psychiatric disorders is limited.7

Case report

A 28-year-old male first presented with stuttering at the age of 7 years. No management was carried out at that time because his symptoms were mild. By the age of 20 years, he was being ridiculed and humiliated by his college classmates. He became more introverted and did not want to communicate with others. Since then, his stuttering had worsened. He experienced multiple blocks in expressing words, including sound and syllable repetitions, circumlocutions, and monosyllabic repetitions, that made it difficult to conduct the interview. In addition to deterioration of his PDS, he developed depression and anxiety and was afraid to communicate with others. He also had physical concomitants of involuntary jerking of his head and upper extremities and muscle spasm of his neck and lower jaw while stuttering. He was diagnosed with depression and anxiety disorder by the psychiatrists at the age of 24 years. He was managed medically with multiple antipsychotics in conjunction with cognitive behavioral therapy. Significant improvement in his psychiatric disorder but not his PDS was achieved at that time. One year earlier, because of his local culture, he had refused to take any medicine, which led to a relapse of his psychiatric symptoms. Subsequent antipsychotics and cognitive behavioral therapy were of limited help in alleviating his psychiatric symptoms. We carefully addressed his treatment options, which included further medical treatment, deep brain stimulation, or capsulotomy. Both the patient and his family opted for capsulotomy for financial reasons and in the hope of being able to avoid using antipsychotics. The surgery was approved by the ethics committee at our hospital. Preoperative magnetic resonance imaging was done to rule out an intracranial tumor, hemorrhage, infarction, and infection. No family history of a speech disorder was reported. The preoperative neuropsychological evaluations were carried out using the 24-item Hamilton Depression Rating Scale,8 the Hamilton Anxiety Rating Scale,9 the Mini-Mental State Examination,10 the similarities and block design subtests of the Wechsler Adult Intelligence scale,11 the logical memory and visual reproduction subtests of the Wechsler Memory Scale,12 and the Wisconsin Card Sorting Test-Simplified (WCST-S).13 Both the logical memory and visual reproduction tests were carried out immediately and after a 30-minute delay. The WCST-S included 48 cards, and his performance was assessed by the number of correct answers, number of errors, number of perseverative errors, number of nonperseverative errors, and number of categories completed. Neuropsychological and PDS evaluations were done before surgery and at 6-month follow-up by the same psychiatrist and speech therapist, who were both aware that the patient had undergone neurosurgery.

Surgery

To better identify the magnetic resonance images without fixation of the head frame were obtained the day before surgery. A 3 T Trio Unite magnetic resonance imaging system (Siemens AG, Muenchen, Germany) was used with T1-weighted and T2-weighted spin-echo sequences in the axial and coronal planes. The slice thickness was 2 mm with an interval gap of 0.02 mm. The preplanning procedure was completed using the Surgi-plan workstation (version 2.1; Elekta Instruments AB, Stockholm, Sweden). On the day of surgery, a Leksell model G head frame (Elekta Instruments AB) was positioned on the skull parallel to the anterior commissure–posterior commissure line under local anesthesia. A repeat magnetic resonance scan with the same parameters as the preplanning scanning was performed using a 1.5 T Sonata Unite magnetic resonance imaging system (Siemens AG). With the help of the Surgi-plan workstation, the prescanned images were then coregistered with the images using location markers. The coordinates of the target and the angles of electrode penetration were calculated. The lesion targets were located 14 mm anterior and 18 mm lateral to the anterior commissure and 5 mm below the anterior commissure–posterior commissure plane. Under the guidance of the Leksell multifunctional stereotactic operation system (Elekta Instruments AB), the lesion electrode was then inserted into the lesion target according to the calculated coordinates. A test stimulation generated by the Elekta neurostimulator at both high frequency (130 Hz) and low frequency (5 Hz) was then carried out to verify the target of the electrode. Next, multiple lesions were produced using the Elekta neurostimulator at 75°C for 70 seconds each. The length of the lesions on both sides was 14 mm (Figures 1 and 2).
Figure 1

Lesions in the anterior limb of the internal capsule 3 months after surgery.

Note: Arrows indicate lesions.

Figure 2

Lesions in the anterior limb of the internal capsule 6 months after surgery.

Note: Arrows indicate lesions.

Post-surgical outcome

The patient’s physical concomitants disappeared on the second day after surgery. Slow reaction, lack of concentration, and mild somnolence were observed during the first week, but most of these symptoms disappeared 10 days after surgery. One month after surgery, the patient reported improvement in his symptoms of depression, anxiety, and PDS, except for some naïve behaviors (sucking and biting his fingers), mild memory loss, and laziness. Three months after surgery, the patient reported being interested in daily life and feeling more confident. Six months after surgery, the patient reported that his psychiatric symptoms were significantly improved. Although the symptoms of his PDS occurred occasionally, these were mild and could be controlled by ego psychology. Complete remission of the naïve behaviors, mild memory loss, and laziness were documented 1 month after surgery. One year after surgery, the patient returned to work, reporting improved mood and better social and work relationships. Although complete remission of his PDS was not achieved, he could communicate with others more fluently.

Stuttering

Six months after surgery, the patient’s symptoms improved from very severe speech impairments on the Stuttering Severity Instrument 314 and 8/9 for speech naturalness15 to mild speech impairments on the Stuttering Severity Instrument 3 and 3/9 for speech naturalness. Both the severity of stuttering and naturalness of speech improved significantly 6 months after surgery.

Neuropsychological status

Neuropsychological evaluations (Table 1) were carried out before surgery, 1 month after surgery, 3 months after surgery, and 6 months after surgery. His scores on the Hamilton Depression Rating Scale and Hamilton Anxiety Rating Scale decreased markedly 6 months after surgery, which is in accordance with the significant improvement in his psychiatric symptoms at 6-month follow-up. Neuropsychological evaluation tests were used to assess and detect whether there were neurocognitive impairments after surgery.
Table 1

Neuropsychological evaluation tests at 6-month follow-up

BFOMASTMASSMAS
HAM-D (24-item)27675
HAM-A224106
MMSE29282930
SIMILARITIES23202221
BD31374138
ILM3.588.58
DLM1.579.58.5
IVR14141414
DVR14141414
WCST-S
 Correct36343840
 Error1214108
 PE61240
 NPE6268
 Categories3333

Abbreviations: BF, before surgery; HAM-D, 24-item Hamilton Depression Rating Scale; HAM-A, Hamilton Anxiety Rating Scale; BD, block design; MMSE, Mini-Mental State Examination; ILM, logical memory subtest of the Wechsler Memory Scale carried out immediately; IVR, visual reproduction subtest of the Wechsler Memory Scale carried out immediately; DLM, logical memory subtest of the Wechsler Memory Scale carried out after a 30-minute delay; DVR, visual reproduction subtest of the Wechsler Memory Scale carried out after a 30-minute delay; NPE, nonperseverative errors; WCST-S, Wisconsin Card Sorting Test-Simplified; PE, perseverative errors; OMAS, 1 month after surgery; TMAS, 3 months after surgery; SMAS, 6 months after surgery.

Cognitive impairment is common in young adults with major depression and anxiety disorder.16 The raw data from the block design, logical memory, and WCST-S indicate that the patient’s impairments of visuospatial function, verbal memory, concentration, and executive function before surgery were significantly improved 6 months after surgery.16 The raw data for the WCST-S at 1 month after surgery, which were lower than the data before surgery but increased at 6-month follow-up, showed that his executive functioning worsened transiently following surgery and improved thereafter. This may be why the patient had naïve behaviors, mild memory loss, and laziness at the 1 month follow-up that completely disappeared 6 months after surgery.13

Discussion

The tics associated with Tourette’s syndrome are defined as involuntary, sudden, rapid, recurrent, nonrhythmic movements (motor tics) or vocalizations (vocal or phonic tics). The onset of Tourette’s syndrome is before the age of 18 years. Patients with Tourette’s syndrome can voluntarily suppress tics for short periods at the expense of mounting inner tension and a subsequent rebound in tic severity.17 Our patient had involuntary movements when he was 20 years old, which occurred only when he stuttered. He was not able to suppress these movements, as in Tourette’s syndrome. We consider these involuntary movements to be physical concomitants of his PDS. The ventral prefrontal cortex is associated with depression, obsessive–compulsive disorder, and several psychiatric disorders.18 The ventral prefrontal cortex (vPFC) projections to the subcortical regions travel primarily in the internal capsule and external capsule. Subcortical fibers pass through the external capsule to the ventral anterior limb of the internal capsule.18 Thus, an anterior capsulotomy may affect the vPFC through the projectional fibers from the vPFC and result in significantly improved psychiatric symptoms. The axons from the vPFC reach cortical targets primarily via the uncinate fasciculus, extreme capsule, and superior longitudinal fasciculus.18 The frontal operculum supporting local phrase structure building was connected via the uncinate fasciculus to the anterior superior temporal gyrus which has been shown to be involved in phrase structure building.19 The extreme capsule is involved in the human language system.20 The superior longitudinal fasciculus is situated in the white matter of the parietal and frontal opercula and extends to the ventral premotor and prefrontal regions.21 All these studies show that there are association fibers between the frontal operculum and the vPFC. The left pars opercularis is where the intrinsic functional architecture of speech–language processes are altered in PDS patients.22 Therefore, an anterior capsulotomy may affect the left pars opercularis through the vPFC and the association fibers between the vPFC and the pars opercularis, which are involved in the language system. The corticostriatothalamocortical (CSTC) pathways project from specific territories in the frontal cortex to corresponding targets within the striatum, then via pathways through the basal ganglia to the thalamus and, finally, with recurrent projections back to the original frontal territory where each loop started; this dysfunction and disorder of the chemistry circuit of the CSTC is a popular basis of neuropsychiatric diseases.23 Dorsal/ventral organization of thalamic/brainstem fibers through the internal capsule results in a complex mingling of thalamic and brainstem axons from various vPFC areas.18 Thus, there are association fibers between the vPFC and the CSTC. Stutterers are likely to exhibit a hypometabolism of the striatum and increased dopamine activity.1,24 Overactivity in the area of the basal ganglia in PDS has been reported in several studies, suggesting that the dopaminergic system plays an important role in the development of stuttering.25,26 Most antipsychotics (Tables 2 and 3) are dopamine receptor antagonists and induce changes in the dopaminergic system and activity of the basal ganglia in the CSTC, and this is followed by improvement in psychiatric symptoms and PDS.1
Table 2

Case reports on the treatment of PDS in adults

ReferenceAge (years)SexTreatment and dose (mg/day)Summary of results
Dias et al324FemaleFluoxetine 20 and Speech therapyFrom severe to moderate speech impairment (IS)
Kumar et al2722MaleFluoxetine 10–20“Complete disappearance” of stuttering
Mozos-Ansorena et al2833MaleOlanzapine 5“Significant improvement” in fluency
Maguire et al2919MaleAsenapine 1075% improvement in fluency (CGI-I) and common side effect of sedation
20MaleAsenapine 560% improvement in fluency (CGI-I)
45MaleAsenapine 560% improvement in speech (CGI-I)
Ranjan et al3042MaleRisperidone 1–2PDS “disappeared completely”
Tavano et al3124MaleRisperidone 0.5“Significant improvement” in stuttering
Tran et al3238MaleAripiprazole 5–1558% reduction in total SSI-3 score
Balamurali et al769FemaleCraniotomy“Improved dramatically”

Abbreviations: IS, Iowa Scale; CGI-I, Clinical Global Impression of Improvement; PDS, persistent developmental stuttering; SSI-3, Stuttering Severity Instrument 3.

Table 3

Controlled studies on the treatment of PDS in adults

ReferencePatients (n)Age (years)Treatment and dose (mg/day)Follow-up durationSummary of result
Maguire et al213218–65Pagoclone 0.3–0.6One year40% reduction in percentage of syllables stuttered (SSI-3, CGI-I), headache was a common adverse event
Maguire et al331620–74Risperidone 0.5–26 weeksRisperidone was superior to a placebo in the percent of syllables stuttered, time spent stuttering, overall stuttering severity, and treatment efficacy; it was well tolerated
Menzies et al343018–66CBTOne yearCBT significantly and sustainably improved psychological functioning but did not improve fluency

Abbreviations: PDS, persistent developmental stuttering; SSI-3, Stuttering Severity Instrument 3; CGI-I, Clinical Global Impression of Improvement; CBT, cognitive behavioral therapy.

Although improvements in PDS were an unexpected outcome in our patient, this report suggests a close relationship between PDS and psychiatric disorders.
  31 in total

Review 1.  Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways.

Authors:  Mohammed R Milad; Scott L Rauch
Journal:  Trends Cogn Sci       Date:  2011-12-02       Impact factor: 20.229

2.  Rules ventral prefrontal cortical axons use to reach their targets: implications for diffusion tensor imaging tractography and deep brain stimulation for psychiatric illness.

Authors:  Julia F Lehman; Benjamin D Greenberg; Cameron C McIntyre; Steve A Rasmussen; Suzanne N Haber
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 3.  Tourette's syndrome.

Authors:  Andrea E Cavanna; Stefano Seri
Journal:  BMJ       Date:  2013-08-20

4.  Increased dopamine activity associated with stuttering.

Authors:  J C Wu; G Maguire; G Riley; A Lee; D Keator; C Tang; J Fallon; A Najafi
Journal:  Neuroreport       Date:  1997-02-10       Impact factor: 1.837

5.  Dynamic processing in the human language system: synergy between the arcuate fascicle and extreme capsule.

Authors:  Tyler Rolheiser; Emmanuel A Stamatakis; Lorraine K Tyler
Journal:  J Neurosci       Date:  2011-11-23       Impact factor: 6.167

6.  Stuttering and speech naturalness.

Authors:  R R Martin; S K Haroldson; K A Triden
Journal:  J Speech Hear Disord       Date:  1984-02

7.  Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients.

Authors:  Christian Rück; Andreas Karlsson; J Douglas Steele; Gunnar Edman; Björn A Meyerson; Kaj Ericson; Håkan Nyman; Marie Asberg; Pär Svanborg
Journal:  Arch Gen Psychiatry       Date:  2008-08

8.  The relationship between mental health disorders and treatment outcomes among adults who stutter.

Authors:  Lisa Iverach; Mark Jones; Sue O'Brian; Susan Block; Michelle Lincoln; Elisabeth Harrison; Sally Hewat; Angela Cream; Ross G Menzies; Ann Packman; Mark Onslow
Journal:  J Fluency Disord       Date:  2009-03-05       Impact factor: 2.538

9.  Stuttering treated with olanzapine: a case report.

Authors:  Alfonso Mozos-Ansorena; Manuela Pérez-García; Begoña Portela-Traba; Angel Tabernero-Lado; Jorge Pérez-Pérez
Journal:  Actas Esp Psiquiatr       Date:  2012-07-01       Impact factor: 1.196

10.  Persistent developmental stuttering: treatment with risperidone.

Authors:  Sanjeev Ranjan; Vinit Sawhney; Prabha S Chandra
Journal:  Aust N Z J Psychiatry       Date:  2006-02       Impact factor: 5.598

View more
  2 in total

1.  Psychosurgery for stuttering.

Authors:  Edgar Durand; Alexander G Weil; Marc Lévêque
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-02       Impact factor: 2.570

2.  Bilateral anterior capsulotomy and amygdalotomy for mental retardation with psychiatric symptoms and aggression: A case report.

Authors:  Shizhen Zhang; Peizhi Zhou; Shu Jiang; Peng Li; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.